Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Volume 1867, Issue 3, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.bbamcr.2019.06.001
Keywords
Heart failure; Myocardial fibrosis; Collagen cross-linking; Lysyl oxidase
Categories
Funding
- Ministerio de Ciencia, Innovacion y Universidades from Spain (Instituto de Salud Carlos III) [CIBERCV CB16/11/00483, PI15/01909, PI18/01469]
- FEDER
- ERA-CVD Joint Transnational Call 2016 LYMIT-DIS [AC16/00020]
Ask authors/readers for more resources
Myocardial interstitial fibrosis (MIF) is a common finding in heart failure (HF) patients, both with preserved and reduced ejection fraction, as well as in HF animal models. MIF is associated with impaired cardiac function and worse clinical outcome. The impact of MIF is influenced not only by the quantity but also by changes in the quality of collagen fibers and in the extracellular matrix components, such as a shift in collagen types proportion, increased fibronectin polymerization and increased degree of collagen cross-linking (CCL). In particular, CCL, a process that renders collagen fibers stiffer and more resistant to degradation, is increased both in patients and animal models of HF. Importantly, in HF patients increased cardiac CCL is directly associated with increased left ventricular stiffness and a higher risk of hospitalization for HF. The aim of this review is to address the complexity of MIF in HF, focusing on CCL.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available